Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis

Daewoong Jo1, Danya Liu, Shan Yao

  • 1Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, 1161 21st Avenue South, A-5321 MCN, Nashville, Tennessee 37232, USA.

Nature Medicine
|July 12, 2005
PubMed

Insights

Suppressor of cytokine signaling 3 (SOCS3) is crucial for controlling inflammation. Researchers developed cell-penetrating SOCS3 (CP-SOCS3) to boost its levels, effectively reducing severe inflammation and protecting against lethal effects.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Suppressor of cytokine signaling 3 (SOCS3) normally limits pro-inflammatory signaling pathways like STAT.
  • Physiological SOCS3 levels may be insufficient to control acute inflammation induced by pathogens (e.g., staphylococcal enterotoxin B [SEB], lipopolysaccharide [LPS]) or lectins (e.g., concanavalin A [ConA]).

Purpose of the Study:

  • To develop and evaluate cell-penetrating SOCS3 (CP-SOCS3) as a therapeutic strategy to counteract acute inflammatory responses.
  • To determine the efficacy of intracellular SOCS3 replenishment in mitigating pathogenic inflammation.

Main Methods:

  • Development of recombinant cell-penetrating forms of SOCS3 (CP-SOCS3).
  • Intracellular delivery of CP-SOCS3 in animal models exposed to SEB, LPS, and ConA.
  • Assessment of CP-SOCS3 distribution, persistence, and its effects on inflammatory cytokine production, liver apoptosis, and necrosis.

Main Results:

  • CP-SOCS3 demonstrated rapid distribution to multiple organs and sustained presence in leukocytes and lymphocytes.
  • CP-SOCS3 administration protected animals from lethal SEB and LPS challenge by reducing inflammatory cytokines and liver damage.
  • CP-SOCS3 effectively reduced ConA-induced liver apoptosis.

Conclusions:

  • Intracellular delivery of SOCS3 using CP-SOCS3 is a viable strategy to suppress severe acute inflammation.
  • Replenishing SOCS3 levels can counteract the detrimental effects of potent inflammatory inducers, offering a potential therapeutic avenue.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.9K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.5K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
12.5K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
121